Differences in Sonographic Conspicuity According to Papillary Thyroid Cancer Subtype: Results of the Ukrainian–American Cohort Study After the Chornobyl Accident
Patrick O'Kane1,
Evgeniy Shelkovoy2,
Robert J. McConnell3,
Victor Shpak2,
Laurence Parker1,
Tatiana I. Bogdanova2,
Alina Brenner4,
Yuri Naida2,
Andrea Frangos1,
Lydia Zablotska5,
Jacob Robbins6,7,
Ellen Greenebaum8,
Lydia Y. Zurnadzhy2,
Mykolo Tronko2 and
Maureen Hatch9
1 Department of Radiology, Thomas Jefferson University Hospital, 10th St. and
Walnut St., 796 Main Bldg., Philadelphia, PA 19107.
2 Institute of Endocrinology and Metabolism, Kyiv, Ukraine.
3 Department of Medicine, The Thyroid Clinic, College of Physicians and
Surgeons, Columbia University, New York, NY.
4 Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics,
National Cancer Institute, Bethesda, MD.
5 Department of Epidemiology, Mailman School of Public Health, Columbia
University, New York, NY.
6 Clinical Endocrinology Branch, National Institute of Diabetes and Digestive
and Kidney Diseases, National Institutes of Health, Bethesda, MD.
7 Deceased.
8 Department of Pathology, College of Physicians and Surgeons, Columbia
University, New York, NY.
9 Division of Cancer Epidemiology and Genetics, National Cancer Institute,
Bethesda, MD.

View larger version (12K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3 —Graph shows mean conspicuity scores for papillary carcinoma
subtypes by reader. Mean score for each subtype differed by reader, but there
was fair agreement among readers on relative conspicuity of each subtype.
|
|

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Copyright © 2008 by the American Roentgen Ray Society.